• Client was nearing the end of clinical study having completed other clinical studies in the past
  • None of the client’s previous submissions to medical conferences were accepted for oral podium presentations and no manuscripts had been published
  • Client believed that the results would be importantly positive and should have a higher profile in the medical community


  • Client doubted whether their data, even if positive, was important enough to the medical community to command a podium presentation
  • Even if accepted for an oral scientific presentation at a top tier conference, deciding on which one conference to target was unclear
  • Client had not cultivated key opinion leader author feedback and advocacy for the candidate or the data
  • No relationships with professional societies’ staff or understanding of the intricate and nonpublic process for the various scientific committees


The Xelay Approach

  • Xelay Acumen conducted an independent and thorough evaluation of the client’s candidate clinical data relative to the marketplace, competition, and needs of various professional societies to determine potential importance of contribution to the medical sciences
  • Xelay Acumen developed a strategic approach to targeting multiple top tier medical conferences, cultivated advocacy amongst opinion leaders and investigators alike, and mapped out individual processes, timelines, and critical steps for the targeted scientific committees
  • In 8 months, Xelay Acumen garnered 10 scientific oral and late-breaking presentations at top-tier medical conferences from just one clinical trial dataset representing 2 weeks of data